enow.com Web Search

  1. Ad

    related to: mtf estrogen without antiandrogen

Search results

  1. Results from the WOW.Com Content Network
  2. Template : Medications and dosages used in hormone therapy ...

    en.wikipedia.org/wiki/Template:Medications_and...

    Estrogen: SC implant: 50–200 mg every 6–24 mos Estradiol valerate: Progynova: Estrogen: Oral: 2–10 mg/day Progynova: Estrogen: Sublingual: 1–8 mg/day Delestrogen [c] Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol cypionate: Depo-Estradiol: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol dipropionate ...

  3. Feminizing hormone therapy - Wikipedia

    en.wikipedia.org/wiki/Feminizing_hormone_therapy

    In modern times, hormone therapy in transgender women is usually done with the combination of an estrogen and an antiandrogen. [356] In some places however, such as Japan, use of antiandrogens is uncommon, and estrogen monotherapy, for instance with high-dose injectable estradiol esters, is still frequently used. [357]

  4. Cyproterone acetate - Wikipedia

    en.wikipedia.org/wiki/Cyproterone_acetate

    Cyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender individuals ...

  5. Pharmacology of cyproterone acetate - Wikipedia

    en.wikipedia.org/wiki/Pharmacology_of_cyprotero...

    [57] [143] [87] However, in spite of strong suppression of testosterone levels, CPA, at least by itself (e.g., without estrogen), is not usually able to reduce testosterone levels into the castrate/female range (<50 ng/dL) at any dosage, and testosterone levels generally remain just above it at levels of roughly 50 to 200 ng/dL.

  6. Template : Target ranges for hormone levels in hormone ...

    en.wikipedia.org/wiki/Template:Target_ranges_for...

    "Providers are encouraged to consult with their local lab(s) to obtain hormone level reference ranges for both 'male' and 'female' norms, [which can vary,] and then apply the correct range when interpreting results based on the current hormonal sex, rather than the sex of registration."

  7. Estradiol valerate - Wikipedia

    en.wikipedia.org/wiki/Estradiol_valerate

    [15] [13] [14] Estradiol valerate is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol. [ 5 ] [ 4 ] [ 16 ] It is an estrogen ester and a prodrug of estradiol in the body.

  8. Gender-affirming hormone therapy - Wikipedia

    en.wikipedia.org/wiki/Gender-affirming_hormone...

    Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.

  9. Comparison of bicalutamide with other antiandrogens

    en.wikipedia.org/wiki/Comparison_of_bicalutamide...

    Comparison of the nonsteroidal antiandrogen (NSAA) bicalutamide with other antiandrogens reveals differences between the medications in terms of efficacy, tolerability, safety, and other parameters. Relative to the other first-generation NSAAs , flutamide and nilutamide , bicalutamide shows improved potency , efficacy, tolerability, and safety ...

  1. Ad

    related to: mtf estrogen without antiandrogen